US approves first medication for severe non-alcoholic fatty liver disease
NEW DELHI: The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease. The medication, Rezdiffra by Madrigal Pharmaceuticals, was found to improve liver scarring in a clinical trial with hundreds of patients suffering from non-alcoholic steatohepatitis (NASH), the most severe form … Read more
